Novartis AG - 예탁증서(보통주)
DE ˙ DB ˙ US66987V1098
€121.00 0.00 (0.00%)
2026-06-04
주가
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionPDS Planning, Inc
Latest Disclosed Ownership9,528 shares
Latest Disclosed Value $ 1,455,402
PDS Planning, Inc reports 0.03% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 21, 2026 - PDS Planning, Inc filed a 13F-HR form disclosing ownership of 9,528 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $1,224,348 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 9,525 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.03% during the quarter. The current value of the position is $1,152,888 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 9,528 3 0.03 1,455 10.81 0.0960
2026-01-26 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 9,525 66 0.70 1,313 8.24 0.0877
2025-10-21 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 9,459 390 4.30 1,213 10.57 0.0839
2025-07-24 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 9,069 172 1.93 1,097 10.70 0.0818
2025-04-24 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 8,897 907 11.35 992 27.54 0.0836
2025-02-10 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,990 -122 -1.50 778 -16.72 0.0691
2024-10-30 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 8,112 33 0.41 933 8.49 0.0836
2024-08-08 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 8,079 314 4.04 860 14.51 0.0868
2024-05-01 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,765 62 0.80 751 -3.35 0.0789
2024-02-01 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,703 277 3.73 778 2.78 0.0886
2023-10-23 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 7,426 672 9.95 756 11.01 0.0979
2023-07-21 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 6,754 1,524 29.14 682 41.58 0.0871
2023-05-02 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 5,230 2,568 96.47 481 99.59 0.0663
2023-01-27 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,662 -138 -4.93 241 13.15 0.0386
2022-11-02 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,800 -787 -21.94 213 -29.70 0.0388
2022-07-15 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,587 384 11.99 303 7.83 0.0548
2022-04-18 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,203 661 26.00 281 26.58 0.0494
2022-01-25 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,542 -377 -12.92 222 -7.11 0.0425
2021-10-22 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,919 -59 -1.98 239 -12.13 0.0551
2021-07-26 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,978 248 9.08 272 16.74 0.0662
2021-04-20 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,730 314 13.00 233 2.19 0.0676
2021-01-21 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,416 -86 -3.44 228 4.59 0.0783
2020-10-19 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,502 6 0.24 218 0.00 0.0888
2020-08-11 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,496 2,496 218 0.0988
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.